ArriVent BioPharma, Inc.
AVBP$33.09▲ 11.11% 24h
$33.09
+$19.67(+146.66%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$1.46B
P/E ratio
—
EPS (diluted)
$-4.32
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
—
Net income
$-166.31M
Net margin
—
Gross margin
—
Dividends & financials
ArriVent BioPharma, Inc. (AVBP) reported revenue of — and net income of $-166.31M, or $-4.32 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
